GLP-1 drugs must have new warning label over incurable blindness condition, says FDA
You’re going to want to keep an eye on this. The Food and Drug Administration warned Monday that GLP-1 drugs may raise the risk of a rare but serious condition that can lead to permanent blindness. The agency is ordering drugmakers to update safety labels on their popular weight-loss and diabetes treatments, alerting patients and … Read more